A potential treatment for sudden liver failure could cut the need for transplants, say scientists at the University of Edinburgh.
The liver has an incredible natural ability to repair itself, but this can be lost in some injuries including severe drug overdoses.
The therapy is a cancer drug that restores this regenerative potential.
The work is at a very early stage, but the team say alternatives to transplant would have a huge impact on patients.
Around 200 people in the UK have sudden life-threatening liver failure each year.
Source: Liver transplants ‘may be unnecessary thanks to new drug treatment’ – BBC News
University of Kentucky doctors are finding results with a new strategy aimed at decreasing the state’s high hepatitis C rate.
Kentucky ranks high among hepatitis C rates nationwide, which is why doctors are looking at battling the disease before it affects patients.
“The prevalence is huge,” UK Emergency Department Dr. Daniel Moore said. “We have a cure, but trying to get the cure to the people that have the disease is a huge challenge.”
Dr. Moore and his team are trying to raise awareness about the challenge by testing everyone who comes into the emergency room for hepatitis C. The hospital started the trial in July, and the results are enough to convince Dr. Moore to keep testing.
“Overall, 11 percent of all the patients that come through our emergency department are positive for having been infected with hepatitis C,” he said.
The percentage was worse for patients in their 20s and 30s. 20 percent of non-baby boomers tested positive for having antibodies ready to fight hepatitis C. Moore said the prevalence of hepatitis C in young patients has spiked about 500 percent in the last five years.
Source: UK HealthCare ER finding hepatitis C before it costs patients